BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31182109)

  • 1. Akt-activated endothelium promotes ovarian cancer proliferation through notch activation.
    Hoarau-Véchot J; Touboul C; Halabi N; Blot-Dupin M; Lis R; Abi Khalil C; Rafii S; Rafii A; Pasquier J
    J Transl Med; 2019 Jun; 17(1):194. PubMed ID: 31182109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-Activated Endothelium Increases Cancer Cell Proliferation and Resistance to Treatment in Ovarian Cancer Cell Organoids.
    Hoarau-Véchot J; Blot-Dupin M; Pauly L; Touboul C; Rafii S; Rafii A; Pasquier J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
    J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer.
    Guerrouahen BS; Pasquier J; Kaoud NA; Maleki M; Beauchamp MC; Yasmeen A; Ghiabi P; Lis R; Vidal F; Saleh A; Gotlieb WH; Rafii S; Rafii A
    Mol Cancer Ther; 2014 Dec; 13(12):3123-36. PubMed ID: 25319392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway.
    Liu Z; Zhu Y; Li F; Xie Y
    Protoplasma; 2020 May; 257(3):901-910. PubMed ID: 31897811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
    Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
    BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
    PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of Wnt and Notch signaling controls ovarian cancer cell survival.
    Bocchicchio S; Tesone M; Irusta G
    J Cell Physiol; 2019 Dec; 234(12):22130-22143. PubMed ID: 31087357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
    Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
    Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
    Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
    Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
    Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicle-carried Jagged-1 inhibits HUVEC sprouting in a 3D microenvironment.
    Tan E; Asada HH; Ge R
    Angiogenesis; 2018 Aug; 21(3):571-580. PubMed ID: 29541959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
    Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
    Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8.
    Pasquier J; Vidal F; Hoarau-Véchot J; Bonneau C; Daraï E; Touboul C; Rafii A
    J Transl Med; 2018 Oct; 16(1):271. PubMed ID: 30285881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.